Cook receives FDA nod for Zenith stent trial

Interventional device firm Cook Medical said it has received U.S. Food and Drug Administration (FDA) clearance to begin a phase I clinical trial for the evaluation of its Zenith Dissection endovascular stent system.

The trial, which will evaluate the system for the treatment of type B thoracic aortic dissections, will include 15 subjects at Thomas Jefferson University Hospital in Philadelphia, the University of Florida in Gainesville, and Massachusetts General Hospital in Boston, according to Cook of Bloomington, IN.

By AuntMinnie.com staff writers
September 24, 2007

Related Reading

Cook expands existing Cardica deal, September 20, 2007

Cook plans manufacturing expansion, September 18, 2007

Cook debuts SonoBiopsy catheter, August 6, 2007

Cook launches new catheter, June 4, 2007

Cook names new executives, January 23, 2007

Copyright © 2007 AuntMinnie.com

Page 1 of 180
Next Page